Cargando…

Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity

Combination antiretroviral therapy (ART) is highly effective in controlling human immunodeficiency virus (HIV)-1 but requires lifelong medication due to the existence of a latent viral reservoir(1,2). Potent broadly neutralizing antibodies (bNAbs) represent a potential alternative or adjuvant to ART...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niessl, Julia, Baxter, Amy E., Mendoza, Pilar, Jankovic, Mila, Cohen, Yehuda Z., Butler, Allison L., Lu, Ching-Lan, Dubé, Mathieu, Shimeliovich, Irina, Gruell, Henning, Klein, Florian, Caskey, Marina, Nussenzweig, Michel C., Kaufmann, Daniel E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018622/ https://www.ncbi.nlm.nih.gov/pubmed/32015556 http://dx.doi.org/10.1038/s41591-019-0747-1

Ejemplares similares

Relationship between intact HIV-1 proviruses in circulating CD4(+) T cells and rebound viruses emerging during treatment interruption
por: Lu, Ching-Lan, et al.
Publicado: (2018)

Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117
por: Cohen, Yehuda Z., et al.
Publicado: (2018)

Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation
por: Cohn, Lillian B., et al.
Publicado: (2018)

RNA flow cytometric FISH for investigations into HIV immunology, vaccination and cure strategies
por: Baxter, Amy E., et al.
Publicado: (2017)

Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells
por: Cohen, Yehuda Z., et al.
Publicado: (2018)

Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir
por: Gaebler, Christian, et al.
Publicado: (2019)

Antigen-responsive CD4(+) T cell clones contribute to the HIV-1 latent reservoir
por: Mendoza, Pilar, et al.
Publicado: (2020)

Combination therapy with anti-HIV-1 antibodies maintains viral suppression
por: Mendoza, Pilar, et al.
Publicado: (2018)

Antibody-mediated prevention and treatment of HIV-1 infection
por: Gruell, Henning, et al.
Publicado: (2018)

Safety and anti-viral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
por: Bar-On, Yotam, et al.
Publicado: (2018)

Harnessing T Follicular Helper Cell Responses for HIV Vaccine Development
por: Niessl, Julia, et al.
Publicado: (2018)

Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function
por: Brunet-Ratnasingham, Elsa, et al.
Publicado: (2022)

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
por: Cho, Alice, et al.
Publicado: (2021)

Human anti–HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness
por: Pietzsch, John, et al.
Publicado: (2010)

Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody
por: Meijers, Matthijs, et al.
Publicado: (2021)

Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies
por: Kreer, Christoph, et al.
Publicado: (2020)

Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy
por: Niessl, Julia, et al.
Publicado: (2020)

Distinct gene expression by expanded clones of quiescent memory CD4(+) T cells harboring intact latent HIV-1 proviruses
por: Weymar, Georg H.J., et al.
Publicado: (2022)

Integration features of intact latent HIV-1 in CD4(+) T cell clones contribute to viral persistence
por: Huang, Amy S., et al.
Publicado: (2021)

Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
por: Muecksch, Frauke, et al.
Publicado: (2022)

Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans
por: Cho, Alice, et al.
Publicado: (2022)

Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
por: Cohen, Yehuda Z., et al.
Publicado: (2019)

Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Primary African Isolates
por: Lorenzi, Julio C. C., et al.
Publicado: (2021)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
por: LaMont, Colin, et al.
Publicado: (2022)

Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals
por: Poopalasingam, Nareshkumar, et al.
Publicado: (2022)

Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans
por: Wang, Zijun, et al.
Publicado: (2022)

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
por: Gruell, Henning, et al.
Publicado: (2022)

Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4
por: Boboila, Cristian, et al.
Publicado: (2010)

Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4
por: Boboila, Cristian, et al.
Publicado: (2013)

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
por: Gruell, Henning, et al.
Publicado: (2022)

Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
por: Wang, Zijun, et al.
Publicado: (2022)

A role for AID in chromosome translocations between c-myc and the IgH variable region
por: Dorsett, Yair, et al.
Publicado: (2007)

A role for AID in chromosome translocations between c-myc and the IgH variable region
por: Dorsett, Yair, et al.
Publicado: (2007)

Persistent Cellular Immunity to SARS-CoV-2 Infection
por: Breton, Gaëlle, et al.
Publicado: (2020)

Persistent cellular immunity to SARS-CoV-2 infection
por: Breton, Gaëlle, et al.
Publicado: (2021)

Prolonged viral suppression with anti-HIV-1 antibody therapy
por: Gaebler, Christian, et al.
Publicado: (2022)

Single-Cell Technologies Applied to HIV-1 Research: Reaching Maturity
por: Sannier, Gérémy, et al.
Publicado: (2020)

Contact-dependent inhibition of HIV-1 replication in ex vivo human tonsil cultures by polymorphonuclear neutrophils
por: Reif, Tatjana, et al.
Publicado: (2021)

Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
por: Vanshylla, Kanika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nj5qqvbv7r2qcrr45qend9h6vb